Tyr130

Site Information
NRGYNLIyRSTRHLK SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 10282519

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	gastric cancer ( 1 ) , gastric carcinoma, surrounding tissue ( 2 )
Relevant cell line - cell type - tissue:	GIST-T1 (gastrointestinal) ( 1 ) , Molm 14 (myeloid) ( 3 ) , stomach ( 2 )

References
1	Takahashi T, et al. (2013) New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis. Int J Cancer 133, 2737-43 23716303 Curated Info
2	Ren H (2009) CST Curation Set: 8059; Year: 2009; Biosample/Treatment: tissue, gastrointestinal tract/untreated; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info
3	Gu T (2009) CST Curation Set: 6979; Year: 2009; Biosample/Treatment: cell line, Molm 14/-; Disease: acute myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info